EDWARDS LIFESCIENCES CORP
Action · US28176E1082 · EW · 936853 (XNYS)
77,52 USD
06.06.2025 21:34
Cours actuels de EDWARDS LIFESCIENCES CORP
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière |
---|---|---|---|---|---|
![]() NYSE |
EW
|
USD
|
06.06.2025 21:34
|
77,52 USD
| 77,77 USD
-0,32 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | -0,89 % | 3,47 % | 7,97 % | 8,37 % | -11,59 % | 4,24 % |
Profil de l'entreprise pour EDWARDS LIFESCIENCES CORP Action
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Fonds investis
Les fonds suivants ont investi dans : EDWARDS LIFESCIENCES CORP investi :
Fonds | Vol. en millions 2.333,18 | Part (%) 4,18 % |
Fonds | Vol. en millions 1.934,56 | Part (%) 1,16 % |
Fonds | Vol. en millions 3.396,32 | Part (%) 0,99 % |
Fonds | Vol. en millions 4.003,88 | Part (%) 0,99 % |
Fonds | Vol. en millions 3.510,12 | Part (%) 0,96 % |
Données de l'entreprise
Nom EDWARDS LIFESCIENCES CORP
Société Edwards Lifesciences Corporation
Symbole EW
Site web
https://www.edwards.com
Marché d'origine
NYSE

WKN 936853
ISIN US28176E1082
Type de titre Action
Secteur Healthcare
Industrie Medical - Devices
PDG Mr. Bernard J. Zovighian
Capitalisation boursière 42 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 15,8 T
Adresse One Edwards Way, 92614 Irvine
Date d'introduction en bourse 2000-03-27
Fractionnements d'actions
Date | Fractionnement |
---|---|
01.06.2020 | 3:1 |
14.12.2015 | 2:1 |
28.05.2010 | 2:1 |
27.05.2010 | 1:1 |
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | EWL.F |
NYSE | EW |
XETRA | EWL.DE |
Autres actions
Les investisseurs qui détiennent EDWARDS LIFESCIENCES CORP ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.